Skip to main content
SpringerLink
Log in

Malignant and Benign Diseases of the Eye and Orbit

  • Chapter
  • First Online:
Handbook of Evidence-Based Radiation Oncology

  • 2663 Accesses

Abstract

This chapter will discuss uveal melanoma, ocular lymphoma, intraocular lymphoma, thyroid ophthalmopathy, and orbital lymphoid hyperplasia (for Retinoblastoma and Rhabdomyosarcoma, see Chap. 41).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Akpek E, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106:1805–10.

    Article  CAS  Google Scholar 

  • Aziz HA, Singh N, Bena J, Wilkinson A, Singh AD. Vision loss following episcleral brachytherapy for uveal melanoma: development of a vision prognostication tool. JAMA ophthalmology. 2016;134(6):615–20.

    Article  Google Scholar 

  • Bell D, et al. Choroidal melanoma: natural history and management options. Cancer Control. 2004;11(5):296–303.

    Article  Google Scholar 

  • Berenbom A, Davila RM, Lin H-S, et al. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye. 2007;21:1198–201.

    Article  CAS  Google Scholar 

  • Bhatia S, et al. Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys. 2002;54:818–21.

    Article  Google Scholar 

  • Bolek T, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys. 1999;44:31–6.

    Article  CAS  Google Scholar 

  • Bradley EA, Gower EW, Bradley DJ, et al. Orbital radiation for graves ophthalmopathy. Ophthalmology. 2008;115:398–409.

    Article  Google Scholar 

  • Chan C, Wallace D. Intraocular lymphoma: update on diagnosis and management. Cancer Control. 2004;11(5):285–95.

    Article  Google Scholar 

  • Chang MY, McCannel TA. Local treatment failure after globe- conserving therapy for choroidal melanoma. Br J Ophthalmol. 2013;97:804–11.

    Article  Google Scholar 

  • Char D, et al. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology. 1988;95:625–30.

    Article  CAS  Google Scholar 

  • Char D, Quivey J, et al. Helium ions versus I-125 brachytherapy in management of uveal melanoma. A prospective, dynamically balanced trial. Ophthalmology. 1993;100:1547–54.

    Article  CAS  Google Scholar 

  • Choudhary MM, Gupta A, Bena J, Emch T, Singh AD. Hepatic ultrasonography for surveillance in pts with uveal melanoma. JAMA Ophthalmol. 2016;134(2):174–80.

    Article  Google Scholar 

  • COMS. Mortality in pts with small choroidal melanoma. COMS report no. 4. Arch Ophthalmol. 1997;115:886.

    Article  Google Scholar 

  • COMS. The COMS randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report no 24. Am J Ophthalmol. 2004;138(6):936.

    Article  Google Scholar 

  • COMS. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28. Arch Ophthalmol. 2006;124:1684.

    Article  Google Scholar 

  • Daftari I, et al. Newer radiation modalities for choroidal tumors. Int Ophthal Clin. 2006;46:69.

    Article  Google Scholar 

  • Diener-West M, et al. Screening for metastasis from choroidal melanoma: the COMS group report 23. J Clin Oncol. 2004;22:2438–44.

    Article  Google Scholar 

  • Diener-West M, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: COMS report no. 26. Arch Ophthalmol. 2005;123(12):1639.

    Article  Google Scholar 

  • Egger E, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys. 2001;51:138.

    Article  CAS  Google Scholar 

  • Esik O, et al. Retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin’s lymphomas. Radiother Oncol. 1996;38:13–8.

    Article  CAS  Google Scholar 

  • Fasola CE, Jones JC, Huang DD, Le QT, Hoppe RT, Donaldson SS. Low-dose radiation therapy (2 Gy× 2) in the treatment of orbital lymphoma. Int J Radiat Oncol Biol Phys. 2013;86(5):930–5.

    Article  Google Scholar 

  • Force, Task, and ABS–OOTF Committee. The American brachytherapy society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy. 2014;13(1):1–14.

    Article  Google Scholar 

  • Gragoudas ES. Proton beam irradiation of uveal melanomas: the first 30 years. Invest Ophthalmol Vis Sci. 2006;47:4666–73.

    Article  Google Scholar 

  • Gragoudas ES, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000;118:773.

    Article  CAS  Google Scholar 

  • Grimm SA, et al. Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report. Ann Oncol. 2007;18:1851–5.

    Article  CAS  Google Scholar 

  • Hoffman PM, et al. Intraocular lymphoma: a series of 14 pts with clinicopathological features and treatment outcomes. Eye. 2003;17:513–21.

    Article  CAS  Google Scholar 

  • Hrbacek J, Mishra KK, Kacperek A, et al. Practice patterns analysis of ocular proton therapy centers: the international OPTIC survey. Int J Radiat Oncol Biol Phys. 2016;95:336–43.

    Article  Google Scholar 

  • Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, Dabaja B, Dharmarajan K, Ng A, Ricardi U, Wirth A. Modern radiation therapy for nodal non-hodgkin lymphoma—target definition and dose guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys. 2014;89(1):49–58.

    Article  Google Scholar 

  • Jeganathan V, Swetha E, Wirth A, MacManus MP. Ocular risks from orbital and periorbital radiation therapy: a critical review. Int J Radiat Oncol Biol Phys. 2011;79(3):650–9.

    Article  Google Scholar 

  • Kath R, et al. Prognosis and treatment of disseminated uveal melanoma. Cancer. 1993;72(7):2219–23.

    Article  CAS  Google Scholar 

  • Kujala E, et al. Very long term prognosis of pts with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651–9.

    Article  Google Scholar 

  • Lanciano R, et al. The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys. 1990;18:407.

    Article  CAS  Google Scholar 

  • Lane AM, Kim IK, Gragoudas ES. Long-term risk of melanoma-related mortality for pts with uveal melanoma treated with proton beam therapy. JAMA Ophthalmol. 2015;133(7):792–6.

    Article  Google Scholar 

  • Le Q, et al. Primary radiotherapy for localized orbital malt lymphoma. Int J Radiat Oncol Biol Phys. 2002;52:657–63.

    Article  Google Scholar 

  • Marucci L, Lane AM, Li W, et al. Conservation treatment of the eye: conformal proton reirradiation for recurrent uveal melanoma. Int J Radiat Oncol Biol Phys. 2006;64:1018–22.

    Article  Google Scholar 

  • Mishra KK, Quivey JM, Daftari IK, Weinberg V, Cole T, Patel K, Castro JR, Phillips TL, Char DH. Long-term results of the UCSF-LBNL randomized trial: charged particle with helium ion versus iodine-125 plaque therapy for choroidal and ciliary body melanoma. Int J Radiat Oncol Biol Phys. 2015a;92(2):376–83.

    Article  Google Scholar 

  • Muller K, Naus N, Nowak PJCM, Schmitz PIM, De Pan C, Van Santen CA, et al. Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results. Radiother Oncol. 2012;102:219–24.

    Article  Google Scholar 

  • Nag S, et al. The American brachytherapy society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys. 2003;56:544.

    Article  Google Scholar 

  • Nathan P, et al. Uveal melanoma UK national guidelines. Eur J Cancer. 2015;51(16):2404–12.

    Article  CAS  Google Scholar 

  • Nguyen LN, Ang K. The orbit. In: Cox J, Ang K, editors. Radiation oncology. 8th ed. St. Louis: Mosby; 2003. p. 282–92.

    Google Scholar 

  • Pelloski CE, et al. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol. 2001;59:145–51.

    Article  CAS  Google Scholar 

  • Peterson IA, et al. Prognostic factors in the radiotherapy of graves’ ophthalmopathy. Int J Radiat Oncol Biol Phys. 1990;19:259–64.

    Article  Google Scholar 

  • Peterson K, et al. The clinical spectrum of ocular lymphoma. Cancer. 1993;72:843–9.

    Article  CAS  Google Scholar 

  • Pfeffer MR, Rabin T, Tsvang L, et al. Orbital lymphoma: is it necessary to treat the entire orbit? Int J Radiat Oncol Biol Phys. 2004;60:527–30.

    Article  Google Scholar 

  • Prabhu RS, Kandula S, Liebman L, Wojno TH, Hayek B, Hall WA, Shu HK, Crocker I.Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(3):643–9.

    Article  Google Scholar 

  • Prummel M, et al. Randomized double-blind trial of prednisone versus radiotherapy in graves’ ophthalmopathy. Lancet. 1993;342:949–54.

    Article  CAS  Google Scholar 

  • Prummel MF, Terwee CB, Gerding MN, et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in pts with mild graves’ ophthalmopathy. J Clin Endocrinol Metab. 2004;89:15–20.

    Article  CAS  Google Scholar 

  • Quivey J, Char D, et al. High intensity 125-iodine (125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys. 1993;26(4):613–8.

    Article  CAS  Google Scholar 

  • Rosenthal S. Benign disease. In: Leibel SA, Phillips TL, editors. Textbook of radiation oncology. 2nd ed. Philadelphia: Saunders; 2004. p. 1525–43.

    Google Scholar 

  • Shields C, Shields J. Diagnosis and management of retinoblastoma. Cancer Control. 2004;11(5):317–27.

    Article  Google Scholar 

  • Shields CL, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol. 2000;118(9):1219–28.

    Article  CAS  Google Scholar 

  • Shields J, et al. Survey of 1264 pts with orbital tumors and simulating lesions. Ophthalmology. 2004;111:997–1008.

    Article  Google Scholar 

  • Stafford SL, et al. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol. 2001;59:139–44.

    Article  CAS  Google Scholar 

  • Straatsma BR, Diener-West M, Caldwell R, Engstrom RE. Mortality after deferral of treatment or no treatment for choroidal melanoma. Am J Ophthalmol. 2003;136(1):47–54.

    Article  Google Scholar 

  • Teckie S, Yahalom J. Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone. Leuk Lymphoma. 2014;55(4):795–801.

    Article  CAS  Google Scholar 

  • Verma V, Mehta MP. Clinical outcomes of proton radiotherapy for uveal melanoma. Clin Oncol. 2016;28(8):e17–27.

    Article  CAS  Google Scholar 

  • Weber DC, Bogner J, Verwey J, et al. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: a comparative study. Int J Radiat Oncol Biol Phys. 2005;63:373–84.

    Article  Google Scholar 

  • Woolf DK, et al. Outcomes of primary lymphoma of the ocular adnexa (orbital lymphoma) treated with radiotherapy. Clin Oncol. 2015;27(3):153–9.

    Article  CAS  Google Scholar 

  • Zytkovicz A, et al. Peripheral dose in ocular treatments with cyberknife and gamma knife radiosurgery compared to proton radiotherapy. Phys Med Biol. 2007;52(19):5957.

    Article  CAS  Google Scholar 

Download references

Acknowledgment

We thank Tania Kaprealian MD, Alice Wang-Chesebro MD, and Jeanne Marie Quivey MD, FACR, for their work on the prior edition of this chapter.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA

    Jason Chan & Kavita K. Mishra

Authors
  1. Jason Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kavita K. Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kavita K. Mishra .

Editor information

Editors and Affiliations

  1. The Oregon Clinic, Providence St. Vincent Medical Center, Portland, OR, USA

    Eric K. Hansen

  2. Department of Radiation Oncology, University of California, San Franc, SAN FRANCISCO, CA, USA

    Mack Roach III

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chan, J., Mishra, K.K. (2018). Malignant and Benign Diseases of the Eye and Orbit. In: Hansen, E., Roach III, M. (eds) Handbook of Evidence-Based Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-62642-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62642-0_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62641-3

  • Online ISBN: 978-3-319-62642-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation